iiinova — where your digital self keeps evolving

Reposted by @schwaintager.bsky.social

Ilan Schwartz @germhuntermd.bsky.social · 17/09/2026

Economic Outcomes of Dalbavancin versus Standard Therapy in Staphylococcus aureus Bacteremia in the DOTS Randomized Clinical Trial Among patients with injection drug use, savings with dalbavancin for SAB were approximately $22,000 💰 academic.oup.com/cid/article/... #IDSky

academic.oup.com

Economic Outcomes of Dalbavancin versus Standard Therapy in Staphylococcus aureus Bacteremia in the DOTS Randomized Clinical Trial

Across all patients in DOTS, mean medical costs associated with Staphylococcus aureus bacteremia were about $4600 to $5900 lower in the dalbavancin group v

2133

Reposted by @schwaintager.bsky.social

Ilan Schwartz @germhuntermd.bsky.social · 11/09/2026

A Scenario-Based Survey of Clinician Recommendations for Follow-up Blood Cultures in Patients with Varying Risk of Persistent Gram-Negative Bacteremia High variability in practice in ordering FU blood cultures in GNB bacteremia Editor’s Choice 🤩 #IDSky academic.oup.com/ofid/advance...

academic.oup.com

Validate User

183

Reposted by @schwaintager.bsky.social

Jonathan Ryder, MD @jonathanrydermd.bsky.social · 04/06/2026

Congrats to my colleagues for this interesting analysis. Looking at patients who met DOTS criteria and receive dalbavancin in our hospital, they differ from the DOTS trial Younger, more IDU, more R-sided IE (less SSTI), and more persistent bacteremia. Yet, outcomes similar #IDSky

2208

schwaintager.bsky.social @schwaintager.bsky.social · 15/05/2026

Last day in the TxID service as a fellow in the OR watching a lung transplant @transplantidnet.bsky.social @aussiedocwolfe.bsky.social what an experience thank you @dukehealth.bsky.social

010

Reposted by @schwaintager.bsky.social

Angela Huttner @angelahuttner.bsky.social · 10/11/2024

@eliowa.bsky.social, you came!☺️ Thought of your simple observation that early-career awards w/age limits leave people out, esp ♀️ It sparked great collaboration But I never did the implementation work So.. IDSky MedSky www.clinicalmicrobiologyandinfection.com/article/S1198-743X(21)00056-2/fulltext/

1419

Reposted by @schwaintager.bsky.social

Ilan Schwartz @germhuntermd.bsky.social · 18/12/2025

Some US transplant centers cater to international patients, mostly from the Middle East. International patients comprise up to 20% of those receiving transplants at some centers (like lungs at Montefiore). Raises important questions about equitability in access. www.nytimes.com/2025/12/16/u...

nytimes.com

Hospitals Cater to ‘Transplant Tourists’ as U.S. Patients Wait for Organs

4269

Reposted by @schwaintager.bsky.social

Brad Spellberg @bradspellberg.bsky.social · 08/12/2025

Hasn't been much discussion of the 40% failure rate to fill ID programs this match year. Interesting. Wonder if anyone is ever going to do anything about that?

051

Reposted by @schwaintager.bsky.social

Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · 24/10/2025

Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380

recruit.apo.ucla.edu

Transplant Infectious Diseases Career Development Position 2026-2027

University of California, Los Angeles is hiring. Apply now!

187

schwaintager.bsky.social @schwaintager.bsky.social · 21/10/2025

Congratulations to my long life mentor for this extraordinary award @idsainfo.bsky.social

000

schwaintager.bsky.social @schwaintager.bsky.social · 28/09/2025

Happy to share our latest work: Waning of vaccine antibodies over 16 years in youth living with HIV 👉 academic.oup.com/ofid/article... Our findings highlight the need for long-term immunity monitoring and tailored booster strategies in vulnerable populations. #HIV #Vaccines #InfectiousDiseases #OFID

academic.oup.com

Diminished Long-term Vaccine Antibody Persistence in Perinatally Youth Living With HIV on cART

TO THE EDITOR—Combined antiretroviral therapy (cART) has significantly improved the clinical outcomes of individuals with perinatally acquired HIV (PHIV).

000

Reposted by @schwaintager.bsky.social

The New Yorker @newyorker.com · 18/09/2025

An early look at next week’s cover: "Remote Control,” by Barry Blitt. nyer.cm/6ApBXER

The cover of the September 29, 2025, issue of The New Yorker.

632384855

Reposted by @schwaintager.bsky.social

JAMA Network Open @jamanetworkopen.com · 13/09/2025

Solid-organ transplant recipients had a higher risk of developing nontuberculous mycobacterial disease compared to the general population, with lung and other organ recipients showing increased mortality associated with the disease. ja.ma/4gpOU3a

JAMA Network Open article: "Nontuberculous Mycobacterial Disease in Solid-Organ Transplant Recipients and the General Population." Published online September 12, 2025. Authors: Seyed M. Hosseini-Moghaddam, Daniel Fridman, Samantha S. M. Drover.

001

schwaintager.bsky.social @schwaintager.bsky.social · 24/08/2025

What an exciting first week at the TxID service!!!!

000

Reposted by @schwaintager.bsky.social

AST IDCOP @ast-idcop.bsky.social · 03/08/2025

First #TxID session at #WTC2025. Let’s learn about MDRO cases!

031

Reposted by @schwaintager.bsky.social

Max Kozlov @maxkozlov.bsky.social · 30/07/2025

The NIH can’t award ANY grants to outside researchers under new WH restriction, reports @wsj.com. The pause came in the form of a footnote from OMB Director Vought, in a document that doles out federal funds to the NIH. Prelude to rescissions, especially after his comments over the weekend?

wsj.com

Trump Administration Puts New Chokehold on Billions in Health-Research Funding

The National Institutes of Health can’t award grants to outside researchers under a new White House restriction.

4160121

Reposted by @schwaintager.bsky.social

Mycoses Study Group Education & Research Consortium @msgerc.bsky.social · 14/07/2025

123

Reposted by @schwaintager.bsky.social

Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · 12/07/2025

Just posted this #TxID fellowship opportunity on @idsainfo.bsky.social @astinfo.bsky.social @ast-idcop.bsky.social @ishlt.bsky.social - please share with any who might be interested in spending a year in LA ! #IDFellow #IDTwitter #IDSky @ucla-id-fellowship.bsky.social @harborucla-id.bsky.social

194

Reposted by @schwaintager.bsky.social

American Journal of Transplantation @amjtransplant.bsky.social · 10/07/2025

AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate. ajt-transplant-id-exchange.squarespace.com

098

Reposted by @schwaintager.bsky.social

Duke Clinical Research Institute @dcrinews.bsky.social · 25/06/2025

DCRI Faculty members Chuan Hong & Michael Pencina recently helped lead two studies that developed frameworks aimed at evaluating the performance, safety, and reliability of large-language models in health care. Learn more: corporate.dukehealth.org/news/duke-un... #AI #MedSky #clinicalresearch

corporate.dukehealth.org

Duke University Sets New National Standard for Safe, Scalable AI in Health Care

DURHAM, N.C. — Duke University School of Medicine researchers have developed two pioneering frameworks designed to evaluate the performance, safety, and reliability of large-language models in health ...

011